Actavis means FTC never should have sued, says 1-800 Contacts counsel

A Supreme Court ruling on the scope of antitrust liability for allegedly anticompetitive pharmaceutical patent settlements should have precluded a Federal Trade Commission challenge to how 1-800 Contacts resolved its trademark disputes, the company's lawyer argued last week.

Get unlimited access to all Global Competition Review content